Its use, new data shows, could boost the economic benefit profile of more “common” drugs-and better inform HTA and payer decision-making. An analysis of 10 years of decision-making by health ...
Seyfarth Synopsis: This is the second in a series of posts that investigate trends in equal pay litigation resulting from the recent uptick in the number and quality of equal pay lawsuits. This post ...